Andrew Collier, Sujoy Ghosh, Mario Hair, Iqbal Malik, Jim McGarvie
OBJECTIVE: Radioiodine therapy is the most commonly used therapy for patients with Graves’ disease (GD) in the United Kingdom. It is considered safe, effective and relatively inexpensive. The aim of our study was to examine the outcome of 131Iodine therapy in patients with GD when two different activities of 131Iodine were used …